摘要:
The invention concerns a method for the production of a pharmaceutical preparation for the treatment of Herpes forms that is characterized in that the preparation comprises at least one antiseptic compound associated with a particular carrier.
摘要:
The present invention relates to liposomal pharmaceutical preparations which include active agents such as antiseptic agents, wound-healing agents, or combinations thereof, useful in the treatment of external wounds. The active agents are encapsulated in liposomes, and the liposomes are incorporated in pharmaceutical preparations such as liquids, ointments, gels, lotions, or creams capable of delivering the active agents to external wound sites. The invention further relates to methods of preparation of the liposomes and the pharmaceutical preparations, and to methods of treatment of external wounds and ophthalmic infections.
摘要:
Disclosed are compositions comprising antiseptic and wound healing agents for the treatment of diseases of the lower respiratory tract and methods.
摘要:
The invention concerns a method for the production of a pharmaceutical preparation for the treatment of Herpes forms that is characterized in, that the preparation comprises at least one anti-septic compound associated with a particular carrier.
摘要:
The present invention relates to liposomal pharmaceutical preparations which include active agents such as antiseptic agents, wound-healing agents, or combinations thereof, useful in the treatment of external wounds. The active agents are encapsulated in liposomes, and the liposomes are incorporated in pharmaceutical preparations such as liquids, ointments, gels, lotions, or creams capable of delivering the active agents to external wound sites. The invention further relates to methods of preparation of the liposomes and the pharmaceutical preparations, and to methods of treatment of external wounds and ophthalmic infections.
摘要:
The present invention is directed to a storage stable package of a iodophor containing particulate pharmaceutically acceptable carrier compositions. The invention is particularly directed to a storage stable package of a PVP-iodine liposome compositions. The packaging material is generally plastic, paper or cardboard.
摘要:
Disclosed in certain embodiments is a controlled release dosage form comprising a matrix comprising a pharmaceutically acceptable salt of an opioid analgesic in a controlled release material; wherein less than 25% of the opioid salt is released after 1 hour of in-vitro dissolution of the dosage form in 900 ml of Simulated Gastric Fluid with 20% ethanol using a USP Apparatus I (basket) apparatus at 100 rpm at 37 degrees C.°.
摘要:
A packet encapsulation scheme for multiplexing application sessions—Lightweight IP Encapsulation (LIPE)—is described. An LIPE packet comprises at least one multiplexing header (NH) and associated multimedia data packet (MDP). The LIPE packet uses UDP/IP as transport. An MH field further comprises a 16-bit a user identifier (UID) field, an 11 bit length indicator (LNG) field, a 1 bit “more” (M) field and an optional payload type/class of service (PT/CoS) field comprising 8 bits.
摘要翻译:描述了用于复用应用会话的轻量级IP封装(LIPE)的分组封装方案。 LIPE分组包括至少一个复用报头(NH)和相关联的多媒体数据分组(MDP)。 LIPE数据包使用UDP / IP作为传输。 MH字段还包括16位用户标识符(UID)字段,11位长度指示符(LNG)字段,1比特“更多”(M)字段和可选的有效载荷类型/服务等级(PT / CoS )字段包括8位。